+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Xeomin"

From
Muscle Spasticity Market Report 2025 - Product Thumbnail Image

Muscle Spasticity Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Muscle Relaxant Drugs Market Report 2025 - Product Thumbnail Image

Muscle Relaxant Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Sialorrhea Treatment - Global Strategic Business Report - Product Thumbnail Image

Sialorrhea Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 278 Pages
  • Global
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Xeomin is a prescription medication used to treat musculoskeletal disorders, such as cervical dystonia, blepharospasm, and strabismus. It is a neuromodulator, meaning it works by blocking the release of certain chemicals in the brain that cause muscle contractions. Xeomin is administered through injections directly into the affected muscle. It is a relatively new drug, having been approved by the FDA in 2011. Xeomin is a popular choice for treating musculoskeletal disorders due to its efficacy and safety profile. It is well-tolerated and has few side effects. It is also easy to administer and does not require refrigeration. The Xeomin market is highly competitive, with several companies offering the drug. These include Merz Pharmaceuticals, Allergan, and Ipsen Biopharmaceuticals. Each company offers its own formulation of Xeomin, with varying concentrations and dosing schedules. Show Less Read more